|
|
40
|
|
|
A231AG
|
|
|
GABAPENTIN 300MG CAP (KWA/ATB)
|
|
|
GABAPENTIN
|
|
|
GABAPENTIN
|
|
|
10X10
|
|
|
A
|
|
|
11.66
|
|
|
0.12
|
|
|
300MG
|
|
|
CAPSULE
|
|
|
180
|
|
|
CAP
|
|
|
KWA
|
|
|
KWALITY PHARMACEUTICALS
|
|
|
ATB
|
|
|
ANSA TRADING BARBADOS LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
Yes
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|